Item

Spatial gene regulatory networks driving cell state transitions during human liver disease

Hammond, Nigel L
Murtuza Baker, Syed
Georgaka, Sokratia
Al-Anbaki, Ali
Jokl, Elliot
Simpson, Kara
Sanchez-Alvarez, Rosa
Athwal, Varinder S
Purssell, Huw
Siriwardena, Ajith K
... show 10 more
Citations
Google Scholar:
Altmetric:
Affiliation
University of Manchester; Manchester University NHS Foundation Trust; University of Cambridge; University of Birmingham; University Hospitals Birmingham NHS Foundation Trust
Other Contributors
Publication date
2025-04-25
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Liver fibrosis is a major cause of death worldwide. As a progressive step in chronic liver disease, fibrosis is almost always diagnosed too late with limited treatment options. Here, we uncover the spatial transcriptional landscape driving human liver fibrosis using single nuclei RNA and Assay for Transposase-Accessible Chromatin (ATAC) sequencing to deconvolute multi-cell spatial transcriptomic profiling in human liver cirrhosis. Through multi-modal data integration, we define molecular signatures driving cell state transitions in liver disease and define an impaired cellular response and directional trajectory between hepatocytes and cholangiocytes associated with disease remodelling. We identify pro-fibrogenic signatures in non-parenchymal cell subpopulations co-localised within the fibrotic niche and localise transitional cell states at the scar interface. This combined approach provides a spatial atlas of gene regulation and defines molecular signatures associated with liver disease for targeted therapeutics or as early diagnostic markers of progressive liver disease.
Citation
Hammond NL, Murtuza Baker S, Georgaka S, Al-Anbaki A, Jokl E, Simpson K, Sanchez-Alvarez R, Athwal VS, Purssell H, Siriwardena AK, Spiers HVM, Dixon MJ, Bere LD, Jones AP, Haley MJ, Couper KN, Bobola N, Sharrocks AD, Hanley NA, Rattray M, Piper Hanley K. Spatial gene regulatory networks driving cell state transitions during human liver disease. EMBO Mol Med. 2025 Jun;17(6):1452-1474. doi: 10.1038/s44321-025-00230-6. Epub 2025 Apr 25.
Type
Article
Description
Publisher
Embedded videos